Completed
Safety, Tolerability and Immunogenic Response of CV-MG01 in Patients With Myasthenia Gravis
NCT02609022
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
- Locations
-
- University Hospital, Antwerp Edegem, Antwerp, Belgium